Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Almond Board of California | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to determine whether inclusion of almonds in a weight loss regimen will augment the rate of weight loss, promote a greater fat mass/fat-free mass ratio of weight loss, improve blood pressure and ameliorate the post-lunch dip in cognitive function.
The purpose of this study is to determine whether inclusion of almonds in a weight loss regimen will augment the rate of weight loss, promote a greater fat mass/fat-free mass ratio of weight loss, improve blood pressure and ameliorate the post-lunch dip in cognitive function.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Energy restriction | Experimental | Energy restriction (-500 kcal/day) (N=40), where participants will receive dietary counseling to reduce energy intake to achieve 500 kcal/day deficits to support weight loss. Participants will also be asked to avoid all nuts during the intervention period. |
|
| Energy restriction with almonds | Experimental | Energy restriction (-500 kcal/day) with dry-roasted, lightly salted almonds supplying 15% of estimated energy requirement. Participants will receive dietary counseling to reduce energy intake to achieve 500 kcal/day deficits. Energy from almonds will be accounted for during dietary modeling so that a 500 kcal/day deficit is achieved. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Energy restriction | Behavioral |
| ||
| Almonds (15% kcal/day) |
| Measure | Description | Time Frame |
|---|---|---|
| Anthropometric measurements | Changes in body weight, BMI, fat mass, waist circumference and abdominal height over 12 weeks | 12 weeks |
| Blood pressure | Blood pressure measurements assessed at baseline, week-4, week-8 and week-12 | 12 weeks |
| Post-lunch cognitive function | Cognitive function assessments will be performed after a standard lunch at baseline and week 12 | 12 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Fasting blood biochemistries | Fasting glucose, insulin, lipids and vitamin E over 12 weeks | 12 weeks |
| Dietary intake | Dietary intakes assessed at baseline, week-1, week-2, week-3, week-4, week-6, week-8 and week-10 |
Not provided
Inclusion Criteria:
Adult participants
Exclusion Criteria:
Those not meeting inclusion criteria.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Purdue University | West Lafayette | Indiana | 47907 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 29955720 | Derived | Dhillon J, Ferreira CR, Sobreira TJP, Mattes RD. Multiple Reaction Monitoring Profiling to Assess Compliance with an Almond Consumption Intervention. Curr Dev Nutr. 2017 Sep 6;1(9):e001545. doi: 10.3945/cdn.117.001545. eCollection 2017 Sep. | |
| 27807041 | Derived | Dhillon J, Tan SY, Mattes RD. Almond Consumption during Energy Restriction Lowers Truncal Fat and Blood Pressure in Compliant Overweight or Obese Adults. J Nutr. 2016 Dec;146(12):2513-2519. doi: 10.3945/jn.116.238444. Epub 2016 Nov 2. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D050177 | Overweight |
| D009765 | Obesity |
| D001835 | Body Weight |
| ID | Term |
|---|---|
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
| D012816 | Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Behavioral |
|
| 10 weeks |
| Appetite ratings | Appetite ratings assessed at baseline, week-4, week-8 and week-12 | 12 weeks |
| Physical activity | Physical activity assessed at baseline, week-4, week-8 and week-12 | 12 weeks |
| D013568 | Pathological Conditions, Signs and Symptoms |